Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032

Overview

The Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market is expected to reach a 11.61 USD Billion by 2032 and is projected to grow at a CAGR of 8.73% from 2025 to 2032.

Revenue, 2024 (USD Billion)

5.97

Forecast, 2032 (USD Billion)

11.61

CAGR, 2024 - 2032

8.73%

Report Coverage

Asia-Pacific

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market 2018-2032 USD Billion

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 5.97 USD Billion
Projected Market Size (2032): 11.61 USD Billion
CAGR (2025-2032): 8.73%

Key Findings of Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market

The Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market was valued at 5.97 USD Billion in 2024.
The Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market is likely to grow at a CAGR of 8.73% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Modern in Mode Segment accounted for the largest share of the market with a revenue of 4.31 USD Billion
The fastest growing segment Immunology in Application Segment grew Fastest with a CAGR of 9.39% during the forecast period from 2024 to 2032.

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market Scope

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market Segmentation & Scope

Application

Rheumatology
Haemato-Oncology
Pulmonology
Neurology
Other Applications
Critical Care
Hematology
Immunology

Product

Monoclonal Antibodies (Derived from Plasma Cells)
Other Plasma Derived Proteins
Protease Inhibitors (For Genetic Deficiencies)
Albumin (Plasma Volume Expander)
Coagulation Factors (For Bleeding Disorders)
Immunoglobulins

Distribution Channel

Others
Third Party Distributors
Direct Tenders

End User

Academic Institutes
Others
Research Labs
Hospitals & Clinics

Mode

Traditional Plasma Fractionation
Modern

Processing Technology

Microfiltration
Ultrafiltration
Cryoprecipitation
Affinity Chromatography
Ion Exchange Chromatography

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market Data Coverage Insights

Study Period	2024-2032
Base Year	2024
Unit	Revenue in USD Billion
Market Value in 2024	5.97 USD Billion
Market Value in 2032	11.61 USD Billion
CAGR (2025-2032)	8.73%
Historic Data	2016-2023
Market Segments Covered	Application,Product,Distribution Channel,End User,Mode,Processing Technology

Regional Insights:

Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 5.97 USD Billion in 2024
- Key Country: China, leading in terms of revenue with value of 1,467.77 USD Million in 2024.

Segments and Scope

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Application
- Immunology is the largest segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 1.67 USD Billion in the year 2024.
- Immunology is the Fastest growing segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 9.39 % in forecast period 2025-2032.
Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Product
- Immunoglobulins is the largest segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 2.47 USD Billion in the year 2024.
- Coagulation Factors (For Bleeding Disorders) is the Fastest growing segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 8.76 % in forecast period 2025-2032.
Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 2.79 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 9.17 % in forecast period 2025-2032.
Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By End User
- Hospitals & Clinics is the largest segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 3.83 USD Billion in the year 2024.
- Hospitals & Clinics is the Fastest growing segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 9.06 % in forecast period 2025-2032.
Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Mode
- Modern is the largest segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 4.31 USD Billion in the year 2024.
- Modern is the Fastest growing segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 8.85 % in forecast period 2025-2032.
Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Processing Technology
- Ion Exchange Chromatography is the largest segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 1.79 USD Billion in the year 2024.
- Affinity Chromatography is the Fastest growing segment in Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 8.84 % in forecast period 2025-2032.

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market Company Share Analysis

Company Name
Octapharma AG
Kedrion S.p.A
Takeda Pharmaceutical Company Limited
Grifols, S.A.
CSL

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market Geographical Sales Distribution, 2018-2032 USD Billion

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market

Middle East & Africa Cold Sore Treatment Market

North America Cold Sore Treatment Market

Europe Cold Sore Treatment Market

Asia-Pacific Cold Sore Treatment Market

Argentina Cold Sore Treatment Market

Australia Cold Sore Treatment Market

Austria Cold Sore Treatment Market

Belgium Cold Sore Treatment Market

Brazil Cold Sore Treatment Market

Frequently Asked Questions

What are the primary segments covered in the Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market?

The Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Application,Product,Distribution Channel,End User,Mode,Processing Technology.

What is the current market size of the Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market?

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 5.97(Revenue in USD Billion) in 2024.

What is the expected growth rate of the Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market?

Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 8.73% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market?

The Modern segment is expected to dominate the Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market, holding a largest market share of 4.31 USD Billion in 2024